Validation of the Immunoscore (IM) as a prognostic marker in stage I/II/III colon cancer: Results of a worldwide consortium-based analysis of 1,336 patients.

Author:

Galon Jerome1,Mlecnik Bernhard1,Marliot Florence1,Ou Fang-Shu2,Bifulco Carlo Bruno3,Lugli Alessandro4,Zlobec Inti4,Rau Tilman T.5,Hartmann Arndt6,Masucci Giuseppe V.7,Zavadova Eva8,Ohashi Pam9,Roehrl Michael H. A.10,Kawakami Yutaka11,Torigoe Toshihiko12,Ascierto Paolo Antonio13,Marincola Franco14,Sargent Daniel J.2,Fox Bernard A.15,Pages Franck1

Affiliation:

1. INSERM, Paris, France;

2. Mayo Clinic, Rochester, MN;

3. Earle A. Chiles Research Institute, Providence Portland Medical Center, Portland, OR;

4. University of Bern, Bern, Switzerland;

5. Institute of Pathology, University Medical Center Erlangen, Erlangen, Germany;

6. University of Erlangen-Nuernberg, Erlangen, Germany;

7. Karolinska Inst, Stockholm, Sweden;

8. Department of Oncology, First Faculty of Medicine, Charles University, Prague 2, Czech Republic;

9. The Princess Margaret Cancer Centre, Toronto, ON, Canada;

10. Biospecimen Sciences Program, University Health Network, Toronto, ON, Canada;

11. Division of Cellular Signaling, Institute for Advanced Medical Research, Tokyo, Japan;

12. Department of Pathology, Sapporo Medical University School of Medicine, Sapporo, Japan;

13. Istituto Nazionale Tumori Fondazione Pascale, Naples, Italy;

14. Research Branch, Sidra Medical and Research Centre, Doha, Qatar;

15. Earle A Chiles Research Institute, Providence Portland Medical Center, Portland, OR;

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3